Mikajaki
Mikajaki is a Swiss medical technology company developing an automated multi-patient ocular diagnostics platform for clinical ophthalmology workflows, founded in 2018 and backed by BlueOcean Ventures.
- Company typePrivate
- Founded2018
- HeadquartersPlan-les-ouates, Switzerland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mikajaki does
Mikajaki is a privately held Swiss medical technology company founded in 2018 and headquartered in Plan-les-Ouates, Switzerland. The company is developing an automated multi-patient ocular diagnostics platform intended to streamline and scale eye diagnostic workflows, based on its self-description as an 'innovative automated multi-patient ocular diagnostics platform.' The platform concept suggests a hardware-software diagnostic system designed to serve clinical and possibly enterprise healthcare settings by automating ocular examinations across multiple patients rather than running single-patient assessments.
The business operates with a small team of 1-10 employees under a leadership trio comprising Jacky Hochner as CEO and co-founder, John Speyrer as CTO/Site Manager, and Michael Assouline as President. In June 2020, the company closed a seed funding round of approximately $2.5M led by BlueOcean Ventures, representing its only disclosed capital event. Other operational details, including product specifications, regulatory clearances, customer deployments, pricing mechanics, revenue model, distribution channels, and partnerships, are not disclosed in the available source material. The company's primary web property (mikajaki.ai) was inaccessible at time of collection, displaying only a verification/loading screen, which significantly limits visibility into the current state of product commercialization, customer traction, and post-2020 operating activity.
As a result, the business model mechanics (how Mikajaki charges customers, the unit economics of its multi-patient platform, and the cadence of capital deployment) cannot be characterized from the available data. The signal set points to an early-stage, pre-commercial medical device venture with AI/automation embedded in its core thesis, but lacking the disclosure footprint needed to assess commercial readiness, regulatory progress, or revenue generation.
Mikajaki firmographics
Firmographics- Name
- Mikajaki
- Website
- https://mikajaki.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Mikajaki is a Swiss medical technology company developing an automated multi-patient ocular diagnostics platform for clinical ophthalmology workflows, founded in 2018 and backed by BlueOcean Ventures.
- Ownership category
- akta.pro rank
Mikajaki industry classification
Industry- Product category
- Ophthalmic Diagnostics Equipment
- NAICS
- Ophthalmic Goods Manufacturing (339115), Diagnostic Imaging Centers (621512)
- SIC
- Optical Instruments & Lenses (3827), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)
- akta.pro secondary industry
- Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)
Keywords
Where Mikajaki is headquartered
LocationHeadquarters
- HQ city
- Plan-les-ouates
- HQ country
- Switzerland
- HQ region
- Europe
Markets served
Mikajaki business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Mikajaki product offering
Product offeringCore offering
Mikajaki develops an innovative automated multi-patient ocular diagnostics platform for the eye-care market. The platform is designed to automate ocular diagnostic workflows and enable screening across multiple patients in clinical settings. The company is based in Plan-les-Ouates, Switzerland, and targets professional eye-care providers such as ophthalmology clinics and hospitals.
Differentiator
Problem solved
Functional benefit
Products and services
- Automated multi-patient ocular diagnostics platform An innovative automated multi-patient ocular diagnostics platform designed for professional eye-care providers. The platform automates ocular diagnostic workflows to enable screening across multiple patients in clinical settings such as ophthalmology clinics, hospital eye departments, and optical retail chains.
Companies that use Mikajaki
Customer profileIdeal customer profiles1 record
Mikajaki technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Mikajaki partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights3 records
Mikajaki competitors and assessment
Company assessmentEmerging players
- Toku Eyes: Toku Eyes (formerly Toku) applies AI to retinal imaging for cardiovascular and metabolic disease risk assessment from fundus photos. Comparable as an AI-first ocular diagnostic company pursuing clinical adoption.
Direct peers
- Digital Diagnostics: Digital Diagnostics pioneered FDA-cleared autonomous AI for diabetic retinopathy diagnosis (IDx-DR). Directly comparable as an AI-first ocular diagnostic platform seeking regulatory clearance and clinical adoption, though substantially more mature.
- Eyenuk: Eyenuk develops EyeArt, an FDA-cleared AI system for autonomous diabetic retinopathy screening used in multi-patient clinic workflows. Closely mirrors Mikajaki's automated multi-patient ocular diagnostics positioning.
- AEYE Health: AEYE Health builds AI-based retinal screening for diabetic retinopathy with FDA clearance, optimized for point-of-care and high-throughput screening. Comparable stage and product thesis as Mikajaki.
- RetinAI: RetinAI (Ikerian AG, Bern) is a Swiss-based AI ocular data and diagnostics company focused on retina imaging and clinical workflow. Directly comparable as a fellow Swiss AI-ophthalmology diagnostics player.
Broad incumbents
- Heidelberg Engineering: Heidelberg Engineering is an established ophthalmic imaging device manufacturer (OCT, fundus, angiography) widely used in clinics globally. Comparable as the incumbent diagnostic imaging platform Mikajaki's AI would integrate with or compete against.
- Optos (Nikon): Optos (now part of Nikon Healthcare) manufactures ultra-widefield retinal imaging devices deployed in eye-care practices. Comparable as a diagnostic imaging hardware incumbent whose installed base Mikajaki would target as workflow software.
- Topcon Healthcare: Topcon Healthcare produces multimodal ophthalmic imaging devices (OCT, fundus) plus its Harmony clinical data platform. Comparable as a broad incumbent whose diagnostic hardware/clinical-software stack Mikajaki's automated platform could complement.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
Mikajaki social profiles
Digital presenceMikajaki financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mikajaki leadership team
Management profileNumber of profiles
Profiles3 records
Mikajaki funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mikajaki M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mikajaki
What does Mikajaki do?
Mikajaki develops an innovative automated multi-patient ocular diagnostics platform for the eye-care market. The platform is designed to automate ocular diagnostic workflows and enable screening across multiple patients in clinical settings. The company is based in Plan-les-Ouates, Switzerland, and targets professional eye-care providers such as ophthalmology clinics and hospitals.
When was Mikajaki founded?
Mikajaki was founded in 2018. It employs 1 to 10 people.
Where is Mikajaki based?
Mikajaki is headquartered in Plan-les-ouates, Switzerland, in the Europe region.
Who are Mikajaki's main competitors?
Toku Eyes is listed as an emerging player. Direct peers are Digital Diagnostics, Eyenuk, AEYE Health and RetinAI. Broad incumbents are Heidelberg Engineering, Optos (Nikon) and Topcon Healthcare.
Does Mikajaki have an API?
No public API is recorded for Mikajaki.
What industry is Mikajaki in?
Mikajaki's product category is Ophthalmic Diagnostics Equipment. Its primary akta.pro industry code is HLAKAKAN, Ocular Imaging & Diagnostic Testing Centers, with a secondary code of HLAFAKAI, Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging). Its NAICS code is 339115 and its SIC code is 3827.